S6E20|从新冠大流行中崛起的 mRNA episode artwork

EPISODE · Jun 29, 2022 · 42 MIN

S6E20|从新冠大流行中崛起的 mRNA

from What's Next|科技早知道 · host 声动活泼

自新冠大流行爆发以来,关于 mRNA 的快速普及和安全争议从未中断。直到今天,仍有不少人好奇,mRNA 为什么会成为解决全球新冠疫情最重要的技术手段。本期节目,「科技早知道」串台「Pfizer Express」,邀请辉瑞的疫苗专家梁家鑫做客,探讨 mRNA 的工作原理和过去三年中的成长轨迹,试图找出未来有哪些全新场景会看到 mRNA 的落地。 风险提示:节目内容仅作学术讨论,嘉宾推荐读物及学术分享仅为嘉宾个人观点。 本期人物 Nina,辉瑞雇主品牌和校园招聘负责人 家鑫,辉瑞医学部 医学事务经理 刘灿,「科技早知道」监制 主要话题 [01:16] mRNA 疫苗安全吗? [07:18] mRNA 发展中最重要的几个时间节点? [16:18] 冷链技术是关键?mRNA最大的优势是? [22:32] mRNA的最新进展? [36:16] 除了新冠,mRNA 还能解决什么?什么是治疗性疫苗? 延伸阅读 Nature 上发表的关于 mRNA 技术发展历史:The tangled history of mRNA vaccines Nature 上发表的关于 mRNA疫苗的综述:mRNA vaccines — a new era in vaccinology mRNA(Messager RNA):信使 RNA,由DNA转录而来,携带遗传信息,1961 年被首次发现,1984 年科学家 Paul Krieg 和 Douglas Melton 在实验室完成了人工合成 mRNA;1995 年 Drew Weissman 和 Katalin Karikó 发现经过修饰的 mRNA 可以逃逸人体的免疫反应;2019 年 mRNA 疫苗作为一种核酸药物被广泛应用在新冠大流行的预防中。 核苷酸(nucleotide):DNA 和 RNA 的基本组成单位,由含氮碱基、糖(核糖或脱氧核糖)、磷酸基团组成;部分单核苷酸会参与能量代谢过程;mRNA疫苗研发中的一个重要环节就是对 mRNA进行修饰,由尿苷异构化所产生的假尿嘧啶核苷(Pseudouridine,PD)是其中一类修饰。 纳米脂质粒(Lipid Nanoparticles):缩写为 LNPs,一种给药途径;在 mRNA 新冠疫苗开发中,就是通过由脂质构成的纳米颗粒包裹在 mRNA 外面,帮助 mRNA 顺利进入人体细胞,解决 mRNA 递送不稳定的问题。 幕后制作 监制:刘灿 后期:Luke,敬文 运营:Yao,Yongxin,Bella,Fiona 设计:饭团 关于节目 原「硅谷早知道」,全新改版后为「What's Next|科技早知道」。放眼全球,聚焦科技发展,关注商业格局变化。 关于我们 声动活泼的宗旨是「用声音碰撞世界」,致力于为人们提供源源不断的思考养料。 我们还有这些播客:声东击西、声动早咖啡、反潮流俱乐部、泡腾 VC、商业WHY酱、跳进兔子洞 欢迎在即刻、微博等社交媒体上与我们互动,搜索 声动活泼 即可找到我们 期待你给我们写邮件,邮箱地址是:[email protected] 如果你喜欢我们的节目,欢迎 打赏支持或把我们的节目推荐给一两位朋友

自新冠大流行爆发以来,关于 mRNA 的快速普及和安全争议从未中断。直到今天,仍有不少人好奇,mRNA 为什么会成为解决全球新冠疫情最重要的技术手段。本期节目,「科技早知道」串台「Pfizer Express」,邀请辉瑞的疫苗专家梁家鑫做客,探讨 mRNA 的工作原理和过去三年中的成长轨迹,试图找出未来有哪些全新场景会看到 mRNA 的落地。 风险提示:节目内容仅作学术讨论,嘉宾推荐读物及学术分享仅为嘉宾个人观点。 本期人物 Nina,辉瑞雇主品牌和校园招聘负责人 家鑫,辉瑞医学部 医学事务经理 刘灿,「科技早知道」监制 主要话题 [01:16] mRNA 疫苗安全吗? [07:18] mRNA 发展中最重要的几个时间节点? [16:18] 冷链技术是关键?mRNA最大的优势是? [22:32] mRNA的最新进展? [36:16] 除了新冠,mRNA 还能解决什么?什么是治疗性疫苗? 延伸阅读 Nature 上发表的关于 mRNA 技术发展历史:The tangled history of mRNA vaccines Nature 上发表的关于 mRNA疫苗的综述:mRNA vaccines — a new era in vaccinology mRNA(Messager RNA):信使 RNA,由DNA转录而来,携带遗传信息,1961 年被首次发现,1984 年科学家 Paul Krieg 和 Douglas Melton 在实验室完成了人工合成 mRNA;1995 年 Drew Weissman 和 Katalin Karikó 发现经过修饰的 mRNA 可以逃逸人体的免疫反应;2019 年 mRNA 疫苗作为一种核酸药物被广泛应用在新冠大流行的预防中。 核苷酸(nucleotide):DNA 和 RNA 的基本组成单位,由含氮碱基、糖(核糖或脱氧核糖)、磷酸基团组成;部分单核苷酸会参与能量代谢过程;mRNA疫苗研发中的一个重要环节就是对 mRNA进行修饰,由尿苷异构化所产生的假尿嘧啶核苷(Pseudouridine,PD)是其中一类修饰。 纳米脂质粒(Lipid Nanoparticles):缩写为 LNPs,一种给药途径;在 mRNA 新冠疫苗开发中,就是通过由脂质构成的纳米颗粒包裹在 mRNA 外面,帮助 mRNA 顺利进入人体细胞,解决 mRNA 递送不稳定的问题。 幕后制作 监制:刘灿 后期:Luke,敬文 运营:Yao,Yongxin,Bella,Fiona 设计:饭团 关于节目 原「硅谷早知道」,全新改版后为「What's Next|科技早知道」。放眼全球,聚焦科技发展,关注商业格局变化。 关于我们 声动活泼的宗旨是「用声音碰撞世界」,致力于为人们提供源源不断的思考养料。 我们还有这些播客:声东击西、声动早咖啡、反潮流俱乐部、泡腾 VC、商业WHY酱、跳进兔子洞 欢迎在即刻、微博等社交媒体上与我们互动,搜索 声动活泼 即可找到我们 期待你给我们写邮件,邮箱地址是:[email protected] 如果你喜欢我们的节目,欢迎 打赏支持或把我们的节目推荐给一两位朋友

NOW PLAYING

S6E20|从新冠大流行中崛起的 mRNA

0:00 42:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

LIGHTS, CAMERA, SMILE! Creatives Club Media Lights, Camera, Smile, is a podcast for anyone with a dream to share something with the world, out of the overflow of themselves - be it their mind, their heart, their personalities, and much more. Each of us are alive in this moment in time, with an innate ability to have ideas and create various things to benefit both ourselves and the people around us for a reason, and here, you will find the encouragement, the inspiration, and the motivation to do just that. Hosted by Cicily, founder of Creatives Club, she dives into various topics surrounding creativity and business. Exploring entrepreneurship for creatives in a corporate reality, sharing tips and tricks in a media centered company, answering questions regarding what a creative actually is are just a few of the things discussed on this podcast. Be encouraged to create for yourself as Cicily gets vulnerable by pivoting the camera to herself for the first time.To submit questions for Cicily to answer, or have her address certain t Solving for Change MOBIA Technology Innovations Solving for Change welcomes business and technology leaders to share stories of bold business transformation within complex organizations. In an era when technology and markets are changing around businesses, the key to staying competitive is to evolve in response to those changes.  MOBIA’s Mike Reeves and Marc LeBlanc investigate business transformation, deconstructing the challenges, ambitions, and market disruptions that drive companies to embark on transformation journeys, and exploring their unique approaches to achieving meaningful outcomes.  What sparks leaders to pursue business transformation? How do they overcome the challenges along the way? What are the keys to creating enduring change?  Through in-depth conversations with business and technology leaders, Mike and Marc answer these questions and explore how businesses evolve by pulling four key transformation levers: people, process, technology, and culture. CISO Perspectives (public) N2K Networks This season on CISO Perspectives, host Kim Jones explores some of the challenges of leading through uncertainty. We explore the complexity of the changing nature of regulation and working with the federal government, the evolution of privacy and fraud, and how emerging technologies like AI and quantum computing are changing cyber. When you don’t know what questions to ask, you’re afraid to ask, or don’t know who to ask, CISO Perspectives provides the foundation for learning in this brave new world. NEWMORROW SESSIONS - A PodCast Series on the Future of Hospitality Mario C. Bauer, Florian Schneider, Axel Weber & Dr. Tillman Bardt The Newmorrow PodCast is more than a podcast — it's a platform for open dialog on the future of our business, a platform for those building what doesn’t exist yet. Here, we share and embrace our passion for the hospitality industry, but we won’t romanticize the journey. We ask the tough questions, confront uncomfortable truths, and prepare for a future that resists easy answers. We believe that the tougher and wilder times become, the more openly, honestly and humanely people need to talk to each other and act together. We believe, openness, togetherness, and truthfulness should also be cornerstones of a professional community to develop our utopian idea of „open source“. This is a space where visionaries don’t just imagine the future — they wrestle with the paradoxes that shape it: success vs. happiness, data vs. instinct, stability vs. reinvention. Join leaders, entrepreneurs, and thinkers as they share not what made them — but what’s actively shaping them, now and next. So tune in

Frequently Asked Questions

How long is this episode of What's Next|科技早知道?

This episode is 42 minutes long.

When was this What's Next|科技早知道 episode published?

This episode was published on June 29, 2022.

What is this episode about?

自新冠大流行爆发以来,关于 mRNA 的快速普及和安全争议从未中断。直到今天,仍有不少人好奇,mRNA 为什么会成为解决全球新冠疫情最重要的技术手段。本期节目,「科技早知道」串台「Pfizer Express」,邀请辉瑞的疫苗专家梁家鑫做客,探讨 mRNA 的工作原理和过去三年中的成长轨迹,试图找出未来有哪些全新场景会看到 mRNA 的落地。 风险提示:节目内容仅作学术讨论,嘉宾推荐读物及学术分享仅为嘉宾个人观点。 本期人物 Nina,辉瑞雇主品牌和校园招聘负责人 家鑫,辉瑞医学部...

Can I download this What's Next|科技早知道 episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!